About this episode
On this episode of TWiV, Novavax COVID-19 vaccine demonstrates 90% overall efficacy, preventing an antigenically disruptive change during growth of influenza virus vaccine in chicken eggs, and MIS-C is driven by loss of the gut mucosal barrier.
Hosts: Vincent Racaniello, Kathy Spindler, and Brianne Barker
Click arrow to play
Download TWiV 769 (68 MB .mp3, 114 min)
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode
- ASV Vaccine Town Hall 2:05
- Novavax vaccine efficacy reported (Novavax)
- H3N2 glycosylation in eggs (TWiV 480)
- Preventing antigenically disruptive HA change in eggs (Cell Host Micr)
- MIS-C due to leaky gut (J Clin Invest)
- Letters read on TWiV 769
- Timestamps by Jolene. Thanks!
Weekly Picks
Brianne – Pandemics for Babies, Germ Theory for Babies, and Vaccines for Babies
Kathy – Playing with Time
Vincent – A Top Virologist in China, at Center of a Pandemic Storm, Speaks Out
Intro music is by Ronald Jenkees
Send your virology questions and comments to [email protected]
Get every episode summarized
Each time This Week in Virology publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from This Week in Virology
TWiV 1309: Maybe they're all cancer vaccines
This Week in Virology
TWiV 1308: Clinical update with Dr. Daniel Griffin
This Week in Virology
TWiV 1307: My heart breaks for flu
This Week in Virology
TWiV 1306: Clinical update with Dr. Daniel Griffin
This Week in Virology